Jeevan Scientific Technology Ltd

Jeevan Scientific Technology Limited announced the successful completion of an inspection by the Central Drugs Standard Control Organization (CDSCO), Hyderabad Zonal Office. The inspection, conducted on June 24, 2026, was for the company's Bioavailability/Bioequivalence (BA/BE) Study Centre located in Balanagar, Hyderabad. This inspection was part of the company's application to add beds to its existing approved BA/BE Study Centre. Jeevan Scientific Technology fully cooperated with the inspection team, which assessed compliance with regulatory guidelines. The company is awaiting further regulatory evaluation following this inspection.

Jeevan Scientific Technology Ltd has announced the closure of its trading window for dealing in the company's securities. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The window will be shut from July 1, 2026, until 48 hours after the declaration of financial results for the quarter ended June 30, 2026. This restriction applies to all designated persons, their immediate relatives, and connected persons. The date of the board meeting to approve these financial results will be communicated separately.

Jeevan Scientific Technology Ltd reports no deviations or variations in the utilization of proceeds from its preferential allotment during the quarter and year ended March 31, 2026. The company confirms adherence to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Funds were allocated for capital expenditure, working capital, subsidiary support, acquisition of API/formulation units, and general corporate purposes. Audit committee and auditor comments are NIL.

Jeevan Scientific Technology Ltd has appointed M/s. KP & Associates, Chartered Accountants, as the Internal Auditors for the financial year 2026-27. The appointment was approved during the Board Meeting held on May 29, 2026. KP & Associates has over 15 years of experience in audit, taxation, financial services, and corporate law.

Jeevan Scientific Technology Ltd reports audited financial results for the year ended March 31, 2026. The company's revenue from operations stood at ₹5393.13 lakhs, compared to ₹4,360.99 lakhs in the previous year. Profit before tax was ₹263.94 lakhs, and profit for the period was ₹165.01 lakhs. The Board of Directors approved these results on May 29, 2026.

Jeevan Scientific Technology Ltd's board meeting on May 29, 2026, approved audited financial results (standalone and consolidated) for the quarter and financial year ended March 31, 2026. They also approved the auditor's report and appointed M/s. KP & Associates as Internal Auditors for FY 2026-27. Additionally, the board approved granting 480,000 stock options to eligible employees and allotted 161,250 equity shares to employees who exercised options under the JSTL-ESOP Scheme 2016.

Jeevan Scientific Technology Ltd has scheduled a Board of Directors meeting on May 29, 2026, to consider and approve the audited financial statements (standalone and consolidated) for the quarter and year ended March 31, 2026. The meeting will also address any other business with the chair's permission.

Nageswar Rao Yarlagadda, Executive Director of Jeevan Scientific Technology Limited, has transferred 100,000 equity shares of the company by way of off-market transaction on 27.03.2026. This disclosure was made under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The transaction details are provided in the disclosure, including the pre and post-transaction holdings of Mr. Yarlagadda.

Nageswar Rao Yarlagadda, Executive Director of Jeevan Scientific Technology Limited, has transferred 1,00,000 equity shares of the company by way of off market on 27.03.2026. This disclosure was made under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The shares transferred represent 0.50% of the total capital of the company.

Jeevan Scientific Technology Ltd has announced the closure of the trading window for dealing in the securities of the company. The closure is in accordance with the Company’s Code of Conduct for Prevention of Insider Trading under SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will remain closed from 01.04.2026 till 48 hours after the declaration of Financial Results for the Quarter and Year ended 31.03.2026 for all designated persons, their immediate relatives and all connected persons covered under the Company’s Code of Conduct. The date of the Board Meeting for the declaration of financial results will be intimated in due course.